FDA Drug Application (202961) for OXCARBAZEPINE by AMNEAL PHARMS

Back to FDA Applications sponsored by AMNEAL PHARMS

Application Number202961
Product Number001
FormSUSPENSION;ORAL
Dosage300MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOXCARBAZEPINE
Active IngredientOXCARBAZEPINE

Active IngredientCount
List of drugs with Active Ingredient OXCARBAZEPINE3


Back to FDA Applications sponsored by AMNEAL PHARMS